📊 Market Overview

U.S. stocks opened the holiday-shortened week lower on Tuesday, September 8, as a spike in oil prices and Middle East geopolitical risk weighed on all three major indexes. The S&P 500 fell 45.08 points (-0.58%) to 7,673.52, the Nasdaq Composite dropped 85.58 points (-0.32%) to 26,421.41, and the Dow Jones Industrial Average slid 628.18 points (-1.18%) to 52,786.07. The Dow's decline was the steepest, as large-cap pharma, financials, and old-economy cyclicals bore the brunt of the selling, while the Nasdaq held up better as semiconductor strength offset software weakness.

Oil dominated the session. Iran-backed Houthi militants struck Saudi Aramco refining and energy facilities in the south of the kingdom with drones and ballistic missiles, wounding at least 73 people and halting operations at several sites. Brent crude broke above $100 a barrel intraday for the first time in three months (session high $100.03), and WTI jumped more than 3% to the mid-$94 range. Iran also warned it "will take action against any threat, even before it is carried out," and raised the prospect of a maritime exclusion zone across the Persian Gulf, keeping a substantial risk premium in energy markets. Canada's retaliatory tariffs on roughly $20 billion of U.S. goods (700-plus product lines at 15–50%) took effect just after midnight, adding to trade tensions.

The "September Fed rate hike" scenario that emerged after Friday's much-hotter-than-expected August jobs report also lingered. That said, the 10-year Treasury yield pared its early gains above 4.8% to around 4.81%, and the dollar index actually fell 0.30%, keeping rate and currency pressure contained. CNN's Fear & Greed Index sat at 42, in "Fear" territory.

🔑 Key Issues

1. Brent Tops $100 for the First Time in Three Months — Middle East Risk Premium Returns The Houthi attacks on Saudi Aramco facilities partly halted southern energy infrastructure, including the 400,000 barrel-a-day Jazan refinery. Brent surged to $100.03 intraday — its highest since July 23 — while WTI rose $2.77 (+3.03%) to $94.25 (October contract). Energy (XLE) was the only sector up more than 1% (+1.11%), and the iShares Global Energy ETF (IXC) climbed to its highest level since its 2001 inception. Capital Economics now sees $100 oil through year-end. Rising crude threatens to push the inflation path back up, a double burden for a market heading into Friday's CPI.

2. Two Novartis Trial Failures — Health Care Sector -2.52%, Amgen -10% Novartis said its Phase 3 trial of pelacarsen, an experimental Lp(a)-lowering drug, enrolled 8,323 patients and lowered Lp(a) levels but missed its primary composite endpoint covering cardiovascular death, non-fatal heart attack, and stroke. A late-stage failure the same day for del-desiran, a treatment for a rare muscle-wasting disease, compounded the damage, sending Novartis (NVS) down 13.9% in its worst day on record. The fallout spread to other Lp(a)-focused developers. Amgen (AMGN) — whose olpasiran uses a different drug design and is still in the Phase 3 OCEAN(a)-Outcomes trial — was hit by a class-wide re-rating and fell 10.08% to $393.17. Ionis (IONS) also dropped sharply. A BMO Capital downgrade added to Amgen's weakness. The ripple pulled down Eli Lilly (-2.21%), AbbVie (-2.99%), Johnson & Johnson (-2.22%), Gilead (-2.89%), and Merck (-1.24%).

3. Intel Jumps 9% — Northland Upgrade Plus CPU Price-Hike Report Lifts Chips Broadly Intel (INTC) surged 9.05% to $104.47 after Northland Securities analyst Gus Richard upgraded the stock to Outperform from Market Perform with a $120 price target, citing a persistent server-processor shortage, progress in Intel's turnaround, and potential benefits from its "Terafab" chip collaboration with Tesla. A supply-chain report that Intel plans to raise PC processor prices about 10% from early October, along with a High-NA EUV production milestone, added fuel. Amid optimism over AI data-center demand, chips defied the broader market: AMD (+5.90%), Arm (+3.74%), Qualcomm (+3.17%), and Broadcom (+2.98%) all rallied, with Qualcomm helped by a deal with Amazon to develop next-generation AI data-center infrastructure. Nvidia (-2.01%), however, fell on profit-taking — a split even within large-cap semis.

4. U.S.-Canada Tariff War Escalates — Canadian Retaliation Takes Effect In response to the U.S. imposing 50% tariffs on $27.6 billion of Canadian goods on August 22, Canada activated retaliatory tariffs of 15–50% just after midnight on roughly $20–27.6 billion of U.S. imports across 700-plus product lines — steel, dairy, appliances, farm equipment, pulp and paper, and electronics. The move, coming right after talks collapsed on Friday, marks a further escalation of a trade conflict that began in early 2025. Tariff-driven price worries, layered onto CPI anxiety, pressured consumer names.

5. Dow -1.18% vs Nasdaq -0.32% — Rotation From Defensives and Old-Economy Into Growth and Energy The decline was less about index levels than sector rotation. Recently strong health care led the drop on the trial failures, followed by financials (XLF -1.38%). Energy (+1.11%), utilities (+0.86%), and technology (+0.32%) rose. With health care, financials, and industrials heavily weighted in the Dow, the index's loss widened, while the Nasdaq was cushioned by chips. Tesla (+3.98%) rebounded after last week's Cybercab-reveal disappointment and NHTSA probe, supported by CEO Elon Musk calling the company's humanoid robot its "biggest product ever."

📊 Sector Performance

Sector	Change	Key Driver
Energy (XLE)	+1.11%	Brent tops $100, Middle East risk premium — the only sector up more than 1%
Utilities (XLU)	+0.86%	Defensive demand amid risk-off, strength in Southern and Duke Energy
Technology (XLK)	+0.32%	Intel, AMD, Arm strength offsets software weakness (CRM, NOW, ADBE)
Real Estate (XLRE)	-0.07%	Roughly flat as the yield rise was contained
Communication Services (XLC)	-0.46%	Meta (-0.53%) soft; Alphabet roughly flat (-0.03%)
Industrials (XLI)	-0.48%	Boeing (-0.72%), GE (-0.66%) weak; Caterpillar (+1.05%) benefits from higher oil
Consumer Staples (XLP)	-0.66%	Walmart (-1.02%) drags; defensives sell off too
Consumer Discretionary (XLY)	-0.80%	Home Depot (-2.29%) slumps; Tesla's rebound cushions the loss
Materials (XLB)	-0.95%	Tariff-driven input-cost worries, cyclical exposure in focus
Financials (XLF)	-1.38%	Wells Fargo (-2.23%), JPMorgan (-1.43%) weak on risk-off selling
Health Care (XLV)	-2.52%	Two Novartis trial failures → Amgen -10%, broad pharma selloff

🌍 Global Markets

• Europe STOXX 600: 649.60 (-0.30, -0.05%) — Novartis's 13.9% plunge dragged the health care sub-index down more than 2%, but energy strength offset it and the index finished roughly flat
• Dollar Index (DXY): 98.86 (-0.30, -0.30%) — the dollar softened despite rate-hike worries
• 10-Year Treasury Yield: 4.81% (+0.02pp, +0.46%) — spiked above 4.8% early, then pared the gain
• WTI Crude: $94.28 (+2.80, +3.06%) — up more than 3% on the Houthi attacks on Saudi facilities; Brent broke $100 intraday
• Gold: $4,400.20 (-29.60, -0.67%) — modestly lower despite safe-haven demand, weighed by the dollar and real yields

🚀 SPCX (SpaceX) Update

SPCX (Space Exploration Technologies Corp.) closed up 3.73% at $153.47. Volume of roughly 85 million shares ran well above the recent average (about 62 million), as investors repositioned ahead of SpaceX's third major lock-up expiration scheduled for September 9. Lock-up expirations typically weigh on a stock on supply concerns, but this time the shares rose as a strong Q2 (revenue of $7.8 billion, up 92% year-over-year) and a rebound from August lows outweighed that. Still, the stock remains about 34% below its June peak of $225.64, consolidating near $150 as it searches for direction. Whether unlocked shares actually flood the market — and whether fresh Starlink or Starship news lands — will drive the stock next week.

⚠️ Investor Caution

With oil near $100 a barrel, worries about a re-acceleration in inflation have grown, making Friday's August CPI the biggest swing factor for this phase. Consensus calls for headline CPI of +2.9% year-over-year (July: +2.7%) and core CPI of +3.1% (unchanged), but if tariff pass-through and higher oil combine, a hotter-than-consensus print is possible — which would raise the odds of a September 16 Fed rate hike and rattle risk assets broadly. Health care's slide looks like a single-catalyst, class-wide re-rating driven by the Novartis failure, so the indiscriminate selling of names with different drug designs, such as Amgen, may be an overreaction. Conversely, Intel's 9% pop leaned heavily on an analyst upgrade and a price-hike report, leaving reversal risk on the table until confirmed by actual results and guidance. Middle East oil volatility and the U.S.-Canada tariff war are structural risks unlikely to resolve quickly.

👁 Watch Tomorrow

• Whether the S&P 500 holds the 7,650 level is the key test. A break below could accelerate the mild correction underway since late August; on a bounce, 7,720–7,750 (early-September highs) is first resistance.
• Whether Brent holds above $100 is the day's biggest variable. Depending on the pace of Saudi facility repairs and further military rhetoric between Iran and the U.S., energy stocks, airlines, and inflation expectations will react immediately. A WTI move above $95 could reinforce the inflation trade.
• Chewy (CHWY) reports before the open on September 9, a gauge of consumer-stock sentiment. After the close on September 10, Oracle (ORCL) and Adobe (ADBE) report together and should set the tone for large-cap software and AI-infrastructure valuations.
• Watch for a health care (XLV) bounce attempt. If Amgen finds support near $393 and rebounds, read it as an oversold snapback; further downside would signal spreading skepticism about the Lp(a) class.
• August PPI is due before the open on September 10. As a leading indicator for CPI, a hotter-than-expected PPI could sharpen CPI anxiety the next day.

💡 Upcoming Events

• 2026-09-09: Chewy (CHWY) quarterly earnings (before the open)
• 2026-09-10: August Producer Price Index (PPI) release (8:30 a.m. ET)
• 2026-09-10: Oracle (ORCL) fiscal Q1 2027 earnings (after the close)
• 2026-09-10: Adobe (ADBE) fiscal Q3 2026 earnings (after the close)
• 2026-09-11: August Consumer Price Index (CPI) release (8:30 a.m. ET)
• 2026-09-11: Kroger (KR) quarterly earnings (before the open)
• 2026-09-16: FOMC rate decision
• 2026-09-30: Micron (MU) fiscal Q4 earnings

📚 Sources

• Stock Market Today (Sept. 8, 2026): S&P 500 edges lower as oil prices climb, Mideast tensions rise — Yahoo Finance
• Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14% — 24/7 Wall St.
• Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO Downgrade — Yahoo Finance
• European Stocks Muted as Novartis Shares Fall Most on Record — Bloomberg
• Intel rises amid Northland Securities upgrade, price hike report — Seeking Alpha
• Why Intel Stock Rallied Tuesday Morning — The Motley Fool
• Intel Leads Chip Stocks Rally as Qualcomm, AMD and Broadcom Stocks Jump — Yahoo Finance
• Oil prices push toward $100/bbl after Houthis attack multiple Saudi energy facilities — Seeking Alpha
• Brent Crude Oil Moves Above $100 for the First Time in 3 Months — Yahoo Finance
• Short Week Packs a Punch: Stocks Down Early on Oil — Charles Schwab
• List of products from the United States subject to counter-tariffs effective September 8, 2026 — Canada.ca
• What to know about Canada's escalating trade war with the U.S. — NPR
• Fantastic News for Tesla Stock Investors! — The Motley Fool
• August CPI Report Forecasts Point to Sticky Inflation and Tariff Pressures — Morningstar
• Adobe (ADBE) Q3 2026 Preview: EPS Est. $6.09, Reports September 10 — AlphaStreet
• Oracle Q1 FY2027 Earnings Preview: Can AI Cloud Growth Deliver? — IG
• SpaceX Stock: 1 Day Left to Share Unlock, How Will SPCX Price React? — CoinGabbar
• SPCX Stock Quote Price and Forecast — CNN